Clara Bohm1, Krista Stewart2, Jennifer Onyskie-Marcus2, Dale Esliger3, Dean Kriellaars4, Claudio Rigatto1. 1. Section of Nephrology, University of Manitoba, Winnipeg, MB, Canada. 2. Winnipeg Regional Health Authority, Winnipeg, MB, Canada. 3. Loughborough University, Leicestershire, UK. 4. School of Medical Rehabilitation, University of Manitoba, Winnipeg, MB, Canada.
Abstract
BACKGROUND: Individuals on hemodialysis have low physical function and activity levels. Clinical trials have shown improvements in these parameters with exercise programming. Pedometers have not been extensively evaluated in individuals on hemodialysis. This randomized clinical trial compared the effects of intradialytic cycling versus a pedometer program on physical function, physical activity and quality of life. METHODS:Sixty patients were randomly assigned to two study groups. The ergometer group cycled during each hemodialysis session for 24 weeks. Pedometer participants followed a home-based walking program for 24 weeks. The primary outcome was aerobic capacity [VO2peak and 6-minute walk (6MW) test]. Secondary outcomes included lower extremity strength [sit-to-stand (SS) test], flexibility [sit-and-reach (SR) test], physical activity (accelerometer) and health-related quality of life. Measurements were collected at baseline and at 12 and 24 weeks. RESULTS: At 12 and 24 weeks, there was no significant change in the VO2peak or 6MW test between or within study groups. SS testing in the ergometer group improved from 10.2 (SD 3.4) to 11.4 (SD 2.5) cycles from baseline to 24 weeks (P < 0.005). Similarly, in the pedometer group, SS cycles improved from 10.1 (SD 3.3) to 12.2 (SD 3.5) (P < 0.005). The SR test also significantly improved over time in both the study groups. No significant changes were noted for other secondary outcomes. CONCLUSIONS: Both intradialytic cycling and pedometer programming improved aspects of physical function. Neither intervention had a significant effect on aerobic capacity. No significant differences in any outcomes were identified between interventions groups.
RCT Entities:
BACKGROUND: Individuals on hemodialysis have low physical function and activity levels. Clinical trials have shown improvements in these parameters with exercise programming. Pedometers have not been extensively evaluated in individuals on hemodialysis. This randomized clinical trial compared the effects of intradialytic cycling versus a pedometer program on physical function, physical activity and quality of life. METHODS: Sixty patients were randomly assigned to two study groups. The ergometer group cycled during each hemodialysis session for 24 weeks. Pedometer participants followed a home-based walking program for 24 weeks. The primary outcome was aerobic capacity [VO2peak and 6-minute walk (6MW) test]. Secondary outcomes included lower extremity strength [sit-to-stand (SS) test], flexibility [sit-and-reach (SR) test], physical activity (accelerometer) and health-related quality of life. Measurements were collected at baseline and at 12 and 24 weeks. RESULTS: At 12 and 24 weeks, there was no significant change in the VO2peak or 6MW test between or within study groups. SS testing in the ergometer group improved from 10.2 (SD 3.4) to 11.4 (SD 2.5) cycles from baseline to 24 weeks (P < 0.005). Similarly, in the pedometer group, SS cycles improved from 10.1 (SD 3.3) to 12.2 (SD 3.5) (P < 0.005). The SR test also significantly improved over time in both the study groups. No significant changes were noted for other secondary outcomes. CONCLUSIONS: Both intradialytic cycling and pedometer programming improved aspects of physical function. Neither intervention had a significant effect on aerobic capacity. No significant differences in any outcomes were identified between interventions groups.
Authors: Gisell Castillo; Justin Presseau; Mackenzie Wilson; Charles Cook; Bonnie Field; Amit X Garg; Christopher McIntyre; Amber O Molnar; Betty Hogeterp; Michelle Thornley; Stephanie Thompson; Jennifer M MacRae; Clara Bohm Journal: Nephrol Dial Transplant Date: 2022-02-25 Impact factor: 7.186
Authors: Amelie Bernier-Jean; Nadim A Beruni; Nicola P Bondonno; Gabrielle Williams; Armando Teixeira-Pinto; Jonathan C Craig; Germaine Wong Journal: Cochrane Database Syst Rev Date: 2022-01-12